Canada markets closed

TRxADE HEALTH, Inc. (MEDS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.29+0.12 (+1.94%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.45M
Enterprise Value 15.40M
Trailing P/E N/A
Forward P/E 21.83
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.73
Price/Book (mrq)15.58
Enterprise Value/Revenue 1.86
Enterprise Value/EBITDA -1.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.93
52-Week Change 36.28%
S&P500 52-Week Change 322.43%
52 Week High 344.56
52 Week Low 33.69
50-Day Moving Average 312.34
200-Day Moving Average 37.93

Share Statistics

Avg Vol (3 month) 3435.66k
Avg Vol (10 day) 319.56k
Shares Outstanding 51.41M
Implied Shares Outstanding 61.41M
Float 8718.92k
% Held by Insiders 124.06%
% Held by Institutions 14.85%
Shares Short (Apr 15, 2024) 420.53k
Short Ratio (Apr 15, 2024) 40.3
Short % of Float (Apr 15, 2024) 42.33%
Short % of Shares Outstanding (Apr 15, 2024) 41.70%
Shares Short (prior month Mar 15, 2024) 455.98k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 22, 2024
Ex-Dividend Date 4Mar 25, 2024
Last Split Factor 21:15
Last Split Date 3Jun 22, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -215.71%
Operating Margin (ttm)-263.25%

Management Effectiveness

Return on Assets (ttm)-55.90%
Return on Equity (ttm)-3,099.92%

Income Statement

Revenue (ttm)8.27M
Revenue Per Share (ttm)10.83
Quarterly Revenue Growth (yoy)4.30%
Gross Profit (ttm)N/A
EBITDA -7.24M
Net Income Avi to Common (ttm)-13.72M
Diluted EPS (ttm)-17.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)151.91k
Total Cash Per Share (mrq)0.11
Total Debt (mrq)7.1M
Total Debt/Equity (mrq)1,309.83%
Current Ratio (mrq)0.24
Book Value Per Share (mrq)0.60

Cash Flow Statement

Operating Cash Flow (ttm)-2.07M
Levered Free Cash Flow (ttm)-2.19M